1451 - 1500 of 7916 Results
Title
Year
-
OPENTitle: Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2247End Page: 2256Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29188Citation Count: 9
- The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II2022OPENTitle: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.994114Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.994114/pdfCitation Count: 1
- Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signals2022OPENTitle: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signalsJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 10Start Page: 2207End Page: 2215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-022-01932-xBest OA location URL: https://www.nature.com/articles/s41591-022-01932-x.pdfCitation Count: 127
-
OPENTitle: Use of Glycolysis‐Enhancing Drugs and Risk of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2210End Page: 2216Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29184Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29184Citation Count: 17
-
OPENTitle: Generation of realistic synthetic data using Multimodal Neural Ordinary Differential EquationsJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00666-xBest OA location URL: https://www.nature.com/articles/s41746-022-00666-x.pdfCitation Count: 7
- Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities2022OPENTitle: Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activitiesJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 184Issue #:Start Page: 106409End Page: 106409Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2022.106409Best OA location URL: http://manuscript.elsevier.com/S1043661822003541/pdf/S1043661822003541.pdfCitation Count: 10
- Low Frequency of p.S510G in PIAS1 Challenges its Relevance for Modifying Repeat Expansion Disorders2022OPENTitle: Low Frequency of p.S510G in PIAS1 Challenges its Relevance for Modifying Repeat Expansion DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2168End Page: 2169Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29191Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29191Citation Count: 1
- Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal Study2022OPENTitle: Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal StudyJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 810End Page: 817Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01455-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01455-8.pdfCitation Count: 4
- Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathy2022OPENTitle: Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00369-wBest OA location URL: https://www.nature.com/articles/s41531-022-00369-w.pdfCitation Count: 15
-
OPENTitle: GPNMB confers risk for Parkinson’s disease through interaction with α-synucleinJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abk0637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870036Citation Count: 77
-
RESTRICTEDTitle: Toward preventing Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 818End Page: 819Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.add7162Citation Count: 14
- Transition Services for Children and Young Adults with Movement Disorders: A Survey by the MDS Task Force on Pediatrics2022OPENTitle: Transition Services for Children and Young Adults with Movement Disorders: A Survey by the MDS Task Force on PediatricsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 972End Page: 978Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13549Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13549Citation Count: 2
-
OPENTitle: Unveiling the B cell receptor structureJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 819End Page: 820Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add8065Best OA location URL: https://discovery.ucl.ac.uk/id/eprint/10156822/1/Tolar_Accepted%20version%20unformatted.pdfCitation Count: 9
- An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utility2022OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 6
- Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach2022RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 8
- Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)2022OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 8
- Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease2022OPENTitle: Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00554-8Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00554-8Citation Count: 21
- Endosomal-Lysosomal and Autophagy Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis2022RESTRICTEDTitle: Endosomal-Lysosomal and Autophagy Pathway in Alzheimer’s Disease: A Systematic Review and Meta-AnalysisJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 88Issue #: 4Start Page: 1279End Page: 1292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-220360Citation Count: 8
-
RESTRICTEDTitle: Genome-wide Association and Meta-analysis of Age at Onset in Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200699Best OA location URL: https://n.neurology.org/content/neurology/99/7/e698.full.pdfCitation Count: 26
-
RESTRICTEDTitle: Neuroprotective Trials in REM Sleep Behavior DisorderJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 19End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200235Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/19.full.pdfCitation Count: 21
-
RESTRICTEDTitle: Outcome Assessment in Parkinson Disease Prevention TrialsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 52End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200236Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/52.full.pdfCitation Count: 13
-
RESTRICTEDTitle: Path to Parkinson Disease PreventionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 76End Page: 83Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200793Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/76.full.pdfCitation Count: 14
- Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐Parkinsonism2022OPENTitle: Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2284End Page: 2289Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29183Citation Count: 6
-
RESTRICTEDTitle: Who to Enroll in Parkinson Disease Prevention Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 10End Page: 18Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200812Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/10.full.pdfCitation Count: 8
-
OPENTitle: Lifestyle Interventions for the Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 42End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200787Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/42.full.pdfCitation Count: 29
-
OPENTitle: Planning for Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200789Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdfCitation Count: 12
- Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's Disease2022OPENTitle: Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2257End Page: 2262Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29189Citation Count: 12
-
OPENTitle: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200786Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdfCitation Count: 14
- Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease2022RESTRICTEDTitle: Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.971252Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.971252/pdfCitation Count: 8
- Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model2022OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 8
- Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases2022OPENTitle: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body DiseasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2086End Page: 2098Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29171Best OA location URL: https://doi.org/10.1002/mds.29171Citation Count: 11
-
OPENTitle: A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200008Best OA location URL: https://ng.neurology.org/content/nng/8/5/e200008.full.pdfCitation Count: 6
-
OPENTitle: Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 2Start Page: 507End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac294Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169283Citation Count: 7
- Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding2022OPENTitle: Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule bindingJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 479Issue #: 17Start Page: 1759End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20220161Best OA location URL: https://portlandpress.com/biochemj/article-pdf/479/17/1759/936843/bcj-2022-0161.pdfCitation Count: 73
- Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson’s Disease2022RESTRICTEDTitle: Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson’s DiseaseJournal Name: Clinical GerontologistPublisher: Informa UK LimitedVol: 47Issue #: 3Start Page: 426End Page: 435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/07317115.2022.2111014Citation Count: 4
- Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches2022RESTRICTEDTitle: Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approachesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.979826Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.979826/pdfCitation Count: 8
- Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade2022RESTRICTEDTitle: Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last DecadeJournal Name: GenesPublisher: MDPI AGVol: 13Issue #: 8Start Page: 1426End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes13081426Best OA location URL: https://www.mdpi.com/2073-4425/13/8/1426/pdf?version=1660204965Citation Count: 5
- Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients2022OPENTitle: Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00366-zBest OA location URL: https://www.nature.com/articles/s41531-022-00366-z.pdfCitation Count: 32
-
RESTRICTEDTitle: The Role of Rab Proteins in Parkinson’s Disease SynaptopathyJournal Name: BiomedicinesPublisher: MDPI AGVol: 10Issue #: 8Start Page: 1941End Page: 1941Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines10081941Best OA location URL: https://www.mdpi.com/2227-9059/10/8/1941/pdf?version=1660634425Citation Count: 15
-
OPENTitle: Gray Matter Volume Loss in Proposed Brain‐First and Body‐First Parkinson's Disease SubtypesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2066End Page: 2074Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29172Best OA location URL: https://doi.org/10.1002/mds.29172Citation Count: 17
-
RESTRICTEDTitle: Scalable approaches for functional analyses of whole-genome sequencing non-coding variantsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: R1Start Page: R62End Page: R72Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac191Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585666Citation Count: 4
-
RESTRICTEDTitle: Parkinson’s Disease and Sugar Intake—Reasons for and Consequences of a Still Unclear CravingJournal Name: NutrientsPublisher: MDPI AGVol: 14Issue #: 15Start Page: 3240End Page: 3240Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu14153240Best OA location URL: https://www.mdpi.com/2072-6643/14/15/3240/pdf?version=1659947851Citation Count: 12
- Views of in‐person and virtual group exercise before and during the pandemic in people with Parkinson disease2022RESTRICTEDTitle: Views of in‐person and virtual group exercise before and during the pandemic in people with Parkinson diseaseJournal Name: PM&RPublisher: WileyVol: 15Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pmrj.12848Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119971Citation Count: 2
-
OPENTitle: Endolysosomal cholesterol export: More than just NPC1Journal Name: BioEssaysPublisher: WileyVol: 44Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/bies.202200111Best OA location URL: https://doi.org/10.1002/bies.202200111Citation Count: 10
- Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutation2022OPENTitle: Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00363-2Best OA location URL: https://www.nature.com/articles/s41531-022-00363-2.pdfCitation Count: 14
- Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysis2022OPENTitle: Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.927573Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.927573/pdfCitation Count: 2
-
OPENTitle: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 888End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26469Best OA location URL: https://diposit.ub.edu/dspace/bitstream/2445/194378/1/730022.pdfCitation Count: 0
- Increasing Computational Protein Design Literacy through Cohort-Based Learning for Undergraduate Students2022OPENTitle: Increasing Computational Protein Design Literacy through Cohort-Based Learning for Undergraduate StudentsJournal Name: Journal of Chemical EducationPublisher: American Chemical Society (ACS)Vol: 99Issue #: 9Start Page: 3177End Page: 3186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jchemed.2c00500Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2022/05/25/2022.05.24.493341.full.pdfCitation Count: 3
- Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease2022OPENTitle: Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 961End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13533Citation Count: 4
-
OPENTitle: Systematic Functional Analysis of PINK1 and PRKN Coding VariantsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 15Start Page: 2426End Page: 2426Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11152426Best OA location URL: https://www.mdpi.com/2073-4409/11/15/2426/pdf?version=1659696395Citation Count: 15